secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2022-08-09T23:59:59+00:00
Accession:  0001558370-22-012914
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta Q3 revenue $133M (+3% YoY); GAAP EPS -$0.09, non-GAAP $0.12
------------------------------------------------------------------

- Revenue $133M (+3% YoY); organic growth 6% despite FX headwind; Services up 6%, Products down 3%.
- GAAP diluted EPS from continuing ops -$0.09; non-GAAP diluted EPS $0.12, flat sequentially.
- Adjusted EBITDA $14M (10.4% margin), down 290 bps sequentially.
- Completed Barkey acquisition for ~€80M; agreed to acquire B Medical for ~€410M, expected close Oct 2022.
- Q4 FY22 guidance: revenue $131-141M, non-GAAP diluted EPS $0.04-$0.12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837022012914/0001558370-22-012914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837022012914/azta-20220809x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-012914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer